BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28735773)

  • 1. Today's fentanyl crisis: Prohibition's Iron Law, revisited.
    Beletsky L; Davis CS
    Int J Drug Policy; 2017 Aug; 46():156-159. PubMed ID: 28735773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl: A Whole New World?
    Rothberg RL; Stith K
    J Law Med Ethics; 2018 Jun; 46(2):314-324. PubMed ID: 30147007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
    Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
    Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
    Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
    Firestone M; Goldman B; Fischer B
    Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug checking as a potential strategic overdose response in the fentanyl era.
    Laing MK; Tupper KW; Fairbairn N
    Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit fentanyls in the opioid street market: desired or imposed?
    Mars SG; Rosenblum D; Ciccarone D
    Addiction; 2019 May; 114(5):774-780. PubMed ID: 30512204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains.
    Gilbert M; Dasgupta N
    Int J Drug Policy; 2017 Aug; 46():160-167. PubMed ID: 28735772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.
    Han Y; Yan W; Zheng Y; Khan MZ; Yuan K; Lu L
    Transl Psychiatry; 2019 Nov; 9(1):282. PubMed ID: 31712552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing prescription opioid, heroin, and fentanyl initiation trajectories: A qualitative study.
    Perdue T; Carlson R; Daniulaityte R; Silverstein SM; Bluthenthal RN; Valdez A; Cepeda A
    Soc Sci Med; 2024 Jan; 340():116441. PubMed ID: 38061222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid analgesics and heroin: Examining drug misuse trends among a sample of drug treatment clients in Kentucky.
    Victor GA; Walker R; Cole J; Logan TK
    Int J Drug Policy; 2017 Aug; 46():1-6. PubMed ID: 28511053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
    Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
    Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe.
    Mounteney J; Giraudon I; Denissov G; Griffiths P
    Int J Drug Policy; 2015 Jul; 26(7):626-31. PubMed ID: 25976511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis.
    Dickson-Gomez J; Krechel S; Spector A; Weeks M; Ohlrich J; Green Montaque HD; Li J
    Subst Abuse Treat Prev Policy; 2022 Jul; 17(1):55. PubMed ID: 35864522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
    Yeo Y; Johnson R; Heng C
    Mil Med; 2022 Aug; 187(9-10):244-247. PubMed ID: 34908134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.
    Unick GJ; Ciccarone D
    Int J Drug Policy; 2017 Aug; 46():112-119. PubMed ID: 28688539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region - United States, 2006-2015.
    O'Donnell JK; Gladden RM; Seth P
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(34):897-903. PubMed ID: 28859052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.
    Dasgupta N; Beletsky L; Ciccarone D
    Am J Public Health; 2018 Feb; 108(2):182-186. PubMed ID: 29267060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts.
    Rose ME
    Pain Med; 2018 Apr; 19(4):793-807. PubMed ID: 28402482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.